Successful pregnancy after inadvertent exposure to cyclophosphamide in the first trimester in a patient with active lupus. Case report

Authors

  • Mauricio Restrepo Escobar Universidad de Antioquia

DOI:

https://doi.org/10.17533/udea.iatreia.10552

Keywords:

Congenital Anomalies, Pregnancy, Lupus Erythematosus, Systemic, Teratogens

Abstract

Cyclophosphamide should be avoided during pregnancy because of its known teratogenic effects. Embryos or fetuses of mothers who require the use of this drug or who have been inadvertently exposed to it usually have an adverse outcome. However, successful pregnancies have occasionally been reported despite the use of cyclophosphamide during it. We report a new case of successful pregnancy in a woman with active renal and neuropsychiatric lupus who had exposure to cyclophosphamide during the first trimester of pregnancy.

|Abstract
= 88 veces | PDF (ESPAÑOL (ESPAÑA))
= 63 veces|

Downloads

Download data is not yet available.

Author Biography

Mauricio Restrepo Escobar, Universidad de Antioquia

Profesor auxiliar, Sección de Reumatología, Departamento de Medicina Interna, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Published

2012-02-06

How to Cite

1.
Restrepo Escobar M. Successful pregnancy after inadvertent exposure to cyclophosphamide in the first trimester in a patient with active lupus. Case report. Iatreia [Internet]. 2012 Feb. 6 [cited 2025 Feb. 2];24(3):Pág. 320-324. Available from: https://revistas.udea.edu.co/index.php/iatreia/article/view/10552

Issue

Section

Case reports

Most read articles by the same author(s)